Wintest
6721
Ridge-i
5572
D. Western Therapeutics Institute
4576
River Eletec
6666
Forside
2330
JP Stock MarketDetailed Quotes
4362 Nippon Fine Chemical
- 2374
- -21-0.88%
20min DelayTrading Dec 16 14:09 JST
60.23BMarket Cap16.22P/E (Static)
2396High2374Low7.00KVolume2395Open2395Pre Close16.70MTurnover317052wk High0.06%Turnover Ratio25.37MShares200852wk Low160.42EPS TTM28.67BFloat Cap3170Historical High16.22P/E (Static)12.08MShs Float255Historical Low146.4EPS LYR0.92%Amplitude72.00Dividend TTM1.12P/B100Lot Size3.03%Div YieldTTM
Nippon Fine Chemical Key Stats
Quarterly+Annual
YOY
| (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | (Q1)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -8.98%33.53B | 1.68%9.23B | -10.59%8.12B | -12.55%8.08B | -14.17%8.1B | 10.13%36.84B | 4.82%9.08B | 6.00%9.08B | 16.03%9.23B | 14.32%9.44B |
| Cost of revenue | -8.81%23.6B | -0.82%6.53B | -9.17%5.68B | -12.17%5.74B | -13.16%5.65B | 11.70%25.88B | 7.52%6.58B | 6.97%6.25B | 17.25%6.54B | 15.67%6.51B |
| Gross profit | -9.37%9.93B | 8.26%2.7B | -13.71%2.44B | -13.46%2.34B | -16.42%2.45B | 6.59%10.96B | -1.71%2.5B | 3.91%2.83B | 13.18%2.7B | 11.42%2.93B |
| Operating expense | -2.83%5.73B | -5.69%1.47B | -0.09%1.44B | -2.50%1.43B | -2.83%1.39B | 9.31%5.9B | 10.09%1.56B | 6.30%1.44B | 10.92%1.47B | 9.96%1.43B |
| Operating profit | -16.99%4.2B | 31.38%1.23B | -27.83%1B | -26.55%903.49M | -29.42%1.06B | 3.59%5.06B | -16.53%939.49M | 1.55%1.39B | 15.99%1.23B | 12.85%1.5B |
| Net non-operating interest income (expenses) | -0.34%32.75M | 184.07%4.71M | -10.03%22.89M | 167.48%1.53M | -30.17%3.62M | 16.58%32.86M | -10.87%1.66M | 9.96%25.44M | 128.80%572K | 76.47%5.19M |
| Non-operating interest income | -0.18%34.06M | 145.99%5.12M | -9.72%23.14M | 110.71%1.91M | -29.30%3.89M | 15.57%34.12M | -14.89%2.08M | 9.92%25.63M | 69.66%906K | 70.63%5.5M |
| Non-operating interest expense | 3.81%1.31M | -2.83%412K | 31.94%252K | 13.47%379K | -14.79%265K | -5.62%1.26M | -27.65%424K | 4.95%191K | 17.61%334K | 9.89%311K |
| Net investment income | 6.29%292.66M | 6.59%40.29M | 13.16%99.21M | -5.65%31.35M | 4.42%121.81M | 53.60%275.35M | 531.23%37.8M | 39.51%87.67M | 51.49%33.22M | 31.80%116.66M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 354.30%889.13M | 564.47%411.99M | -71.62%41.89M | 8,247.70%435.25M | 0 | 7,045.14%195.71M | 2,586.09%62M | 147.6M | -5.34M | -8.55M |
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | -1,140.83%-599.73M | -1,295.94%-136.5M | -120.52%-15.72M | -5,867.82%-447.11M | 76.50%-403K | 153.72%57.62M | 82.81%-9.78M | 1,463.08%76.61M | 68.63%-7.49M | 91.79%-1.72M |
| Less:Impairment of capital assets | --125.11M | --95.57M | --13.7M | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Less:Other special charges | 128.80%16.59M | -9.00%8.9M | 102.63%2.01M | -29.54%5.28M | -76.50%403K | -426.18%-57.62M | 129.88%9.78M | -1,463.08%-76.61M | -68.63%7.49M | -91.79%1.72M |
| Less:Write off | --458.03M | --32.03M | --0 | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Other non-operating income (expenses) | 122.65%54.65M | 1,138.05%22.72M | 142.53%12.2M | 32.25%10.44M | -32.74%9.29M | -35.00%24.54M | -117.00%-2.19M | -38.41%5.03M | -6.07%7.89M | 66.15%13.81M |
| Income before tax | -13.75%4.87B | 53.31%1.58B | -32.83%1.16B | -25.73%934.95M | -26.60%1.19B | 12.48%5.64B | -5.33%1.03B | 18.90%1.73B | 17.96%1.26B | 15.44%1.62B |
| Income tax | -2.00%1.45B | 560.05%525.94M | -34.37%340.05M | -33.37%248.08M | -34.17%334.19M | 1.61%1.48B | -70.98%79.68M | 15.12%518.16M | 18.78%372.33M | 21.94%507.63M |
| Net income | -17.92%3.42B | 10.77%1.05B | -32.18%823.42M | -22.52%686.88M | -23.15%857.26M | 16.92%4.17B | 16.85%949.3M | 20.59%1.21B | 17.62%886.56M | 12.71%1.12B |
| Net income continuous operations | -17.92%3.42B | 10.77%1.05B | -32.18%823.42M | -22.52%686.88M | -23.15%857.26M | 16.92%4.17B | 16.85%949.3M | 20.59%1.21B | 17.62%886.56M | 12.71%1.12B |
| Noncontrolling interests | 6.51%91.44M | -0.55%21.98M | 35.54%25.13M | -14.34%22.03M | 14.43%22.29M | -4.90%85.85M | -1.91%22.1M | -20.29%18.54M | 29.32%25.72M | -20.77%19.48M |
| Net income attributable to the company | -18.43%3.33B | 11.04%1.03B | -33.23%798.29M | -22.77%664.85M | -23.82%834.97M | 17.49%4.08B | 17.39%927.2M | 21.56%1.2B | 17.31%860.84M | 13.56%1.1B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -18.43%3.33B | 11.04%1.03B | -33.23%798.29M | -22.77%664.85M | -23.82%834.97M | 17.49%4.08B | 17.39%927.2M | 21.56%1.2B | 17.31%860.84M | 13.56%1.1B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -16.06%146.4 | 11.98%45.61 | -31.03%35.07 | -20.07%29.12 | -21.14%36.6 | 19.20%174.42 | 22.09%40.73 | 22.77%50.85 | 17.90%36.43 | 14.20%46.41 |
| Diluted earnings per share | -16.06%146.4 | 12.20%45.61 | -31.03%35.07 | -20.07%29.12 | -21.14%36.6 | 19.20%174.42 | 21.85%40.6504 | 22.78%50.85 | 17.90%36.43 | 14.20%46.41 |
| Dividend per share | 22.81%70 | 20.69%35 | 0 | 25.00%35 | 0 | 5.56%57 | 0.00%29 | 0 | 12.00%28 | 0 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
